The Cooper Companies, Inc. (COO) Debt to Equity Ratio: 0.34
Is The Cooper Companies, Inc.’s debt to equity ratio high or low?
The Cooper Companies, Inc.'s debt to equity ratio of 0.34 is in line with its 5-year average of 0.36, around the middle of its 5-year range (0.21–0.54).
As of Sunday, June 14, 2026. 3.03% above its 12-month average of 0.33.
COO Debt to Equity Ratio Chart
COO Average Debt to Equity Ratio Chart
COO Current vs Average Debt to Equity Ratio Chart
COO Debt to Equity Ratio Metrics
DEBT TO EQUITY RATIO
0.34
DEBT TO EQUITY RATIO AVG TTM
0.33
DEBT TO EQUITY RATIO AVG 3Y
0.35
DEBT TO EQUITY RATIO AVG 5Y
0.36
DEBT TO EQUITY RATIO AVG 10Y
0.42
DEBT TO EQUITY RATIO AVG 15Y
0.38
DEBT TO EQUITY RATIO AVG 20Y
0.42
CURRENT VS TTM AVG
+3.03%
CURRENT VS 3Y AVG
-2.16%
CURRENT VS 5Y AVG
-4.67%
CURRENT VS 10Y AVG
-19.05%
CURRENT VS 15Y AVG
-9.93%
CURRENT VS 20Y AVG
-19.59%
COO Competitors' Debt to Equity Ratio
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 0.34 | 0.33 | 0.35 | 0.36 |
| Solventum Corporation (SOLV) | $13.66B | 1.00 | 1.85 | 1.10 | 0.74 |
| Align Technology, Inc. (ALGN) | $12.52B | 0.03 | 0.03 | 0.03 | 0.03 |
| Baxter International Inc. (BAX) | $10.77B | 1.63 | 1.78 | 2.05 | 1.83 |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | 3.23 | 2.45 | 1.88 | 1.68 |
| Hologic, Inc. (HOLX) | $16.97B | 0.52 | 0.52 | 0.55 | 0.69 |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 0.97 | 0.88 | 0.91 | 0.99 |
| Tempus AI, Inc. (TEM) | $8.35B | 1.66 | 4.99 | 4.99 | 4.99 |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 0.21 | 0.21 | 0.18 | 0.13 |
| Moderna, Inc. (MRNA) | $19.80B | 0.22 | 0.15 | 0.11 | 0.10 |
Financial Health
Debt/Equity
0.34
Current Ratio
1.89
The Cooper Companies, Inc. Debt to Equity Ratio Formula & Definition
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. Debt to Equity Ratio FAQ
- What is the debt to equity ratio for The Cooper Companies, Inc. (COO)?
- The debt to equity ratio for COO stock is 0.34.
- Is The Cooper Companies, Inc.'s debt to equity ratio high or low?
- The Cooper Companies, Inc.'s debt to equity ratio of 0.34 is in line with its 5-year average of 0.36, around the middle of its 5-year range (0.21–0.54).
- What is the TTM average debt to equity ratio for The Cooper Companies, Inc. (COO)?
- The TTM average debt to equity ratio for COO stock is 0.33.
- What is the 3Y average debt to equity ratio for The Cooper Companies, Inc. (COO)?
- The 3Y average debt to equity ratio for COO stock is 0.35.
- What is the 5Y average debt to equity ratio for The Cooper Companies, Inc. (COO)?
- The 5Y average debt to equity ratio for COO stock is 0.36.
- What is the 10Y average debt to equity ratio for The Cooper Companies, Inc. (COO)?
- The 10Y average debt to equity ratio for COO stock is 0.42.
- What is the 15Y average debt to equity ratio for The Cooper Companies, Inc. (COO)?
- The 15Y average debt to equity ratio for COO stock is 0.38.
- What is the 20Y average debt to equity ratio for The Cooper Companies, Inc. (COO)?
- The 20Y average debt to equity ratio for COO stock is 0.42.
The Cooper Companies, Inc. Debt to Equity Ratio History
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2025-10-31 | 0.34 |
| 2024-10-31 | 0.32 |
| 2023-10-31 | 0.34 |
| 2022-10-31 | 0.39 |
| 2021-10-31 | 0.21 |
| 2020-10-31 | 0.54 |
| 2019-10-31 | 0.50 |
| 2018-10-31 | 0.61 |
| 2017-10-31 | 0.37 |
| 2016-10-31 | 0.49 |
| 2015-10-31 | 0.51 |
| 2014-10-31 | 0.54 |
| 2013-10-31 | 0.14 |
| 2012-10-31 | 0.17 |
| 2011-10-31 | 0.20 |
| 2010-10-31 | 0.37 |
| 2009-10-31 | 0.51 |
| 2008-10-31 | 0.64 |
| 2007-10-31 | 0.60 |
| 2006-10-31 | 0.54 |
| 2005-10-31 | 0.55 |
| 2004-10-31 | 0.30 |
| 2003-10-31 | 0.44 |
| 2002-10-31 | 0.53 |
| 2001-10-31 | 0.27 |
| 2000-10-31 | 0.24 |
| 1999-10-31 | 0.38 |
| 1998-10-31 | 0.62 |
| 1997-10-31 | 0.09 |
| 1996-10-31 | 3.18 |
Related Metrics
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White